The pilot project is part of Project Mosaic, an effort to create better disease models of sporadic ALS and spur development of precision drugs.

The partnership integrates Ainnocence's AI-driven drug discovery platform with Obatala Sciences' pioneering human-derived 3D stem cell-based and organoid models, creating a powerful solution that ...

CAMBRIDGE, Mass.-- (BUSINESS WIRE)-- Parallel Bio, a biotech company pioneering human-first drug discovery, today announced it has raised $21 million Series A funding, led by AIX Ventures. The ...

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat ...

Beyond students writing essays with ChatGPT and people generating memes with Gemini, artificial intelligence is facilitating ...

Once thought improbable, in vitro human models are demonstrating technological prowess in a growing range of applications.

Following the proof-of-concept project, the pharmaceutical division of JT plans to further advance the development of Quantum AI-driven drug discovery technology and then use quantum computing ...

Joseph Coates, left, owes his life to an A.I. model developed by Dr. David Fajgenbaum and the rest of his team. Hannah Yoon for The New York Times ...